<DOC>
	<DOC>NCT00991016</DOC>
	<brief_summary>To assess the safety and tolerability of escalating single and multiple doses of the compound in healthy volunteers</brief_summary>
	<brief_title>Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy males and females of nonchildbearing potential. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>